Page results
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
File results
-
Patient daily headache diary
-
Patient telephone reminder service opt-out form
-
Living with sickle cell disorder guide for patients
-
-
FOI/2023/0820 - Antenatal classes offered in person and online
-
FOI/2021/0040 - Trust's online clinic/video consultation system
-
FOI/2020/0653 - Contract/ framework/ tender used to buy microcatheters
-
FOI/2023/0825 - Treatments for any disease, Berinert, Cinryze, Orladeyo etc/ hereditary angioedema (HAE)
-
-